Angina With Extremely Serious Operative Mortality Evaluation ) Investigators of Veterans Affairs Cooperative Studies Program # 385 ( AWESOME :

Copyright © 2006 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online 72514 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX DOI: 10.1161/CIRCULATIONAHA.105.570838 2006;114;1251-1257; originally published online Sep 11, 2006; Circulation Angina With Extremely Serious Operative Mortality Evaluation) Investigators of Veterans Affairs Cooperative Studies Program #385 (AWESOME: Cao, Christopher Lyttle, Denise M. Hynes, William G. Henderson and for the Kevin T. Stroupe, Douglass A. Morrison, Mark A. Hlatky, Paul G. Barnett, Lishan Coronary Intervention for Revascularization of High-Risk Patients Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous http://circ.ahajournals.org/cgi/content/full/114/12/1251 located on the World Wide Web at: The online version of this article, along with updated information and services, is

[1]  I. Palacios,et al.  Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). , 2005, Journal of the American College of Cardiology.

[2]  Patrick W Serruys,et al.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.

[3]  D. Morrison.  Cardiac revascularization of the medically refractory elderly patient: it is TIME to pay the piper. , 2004, European heart journal.

[4]  M. Pfisterer,et al.  Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). , 2004, European heart journal.

[5]  M. Pfisterer.  Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME) , 2004, Circulation.

[6]  Ameet Bakhai,et al.  Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial , 2004, Circulation.

[7]  M. Flather,et al.  One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial , 2004, Heart.

[8]  T. Wagner,et al.  Average Cost of VA Rehabilitation, Mental Health, and Long-Term Hospital Stays , 2003, Medical care research and review : MCRR.

[9]  P. Barnett.  Determination of VA Health Care Costs , 2003, Medical care research and review : MCRR.

[10]  T. Wagner,et al.  Using Average Cost Methods to Estimate Encounter-Level Costs for Medical-Surgical Stays in the VA , 2003, Medical care research and review : MCRR.

[11]  Wei Yu,et al.  Estimating the Costs of VA Ambulatory Care , 2003, Medical care research and review : MCRR.

[12]  J. Rumsfeld,et al.  Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. , 2003, Journal of the American College of Cardiology.

[13]  S. Pauker,et al.  A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. , 2003, Journal of the American College of Cardiology.

[14]  M. Pfisterer,et al.  Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. , 2003, JAMA.

[15]  Charles Maynard,et al.  A primer and comparative review of major US mortality databases. , 2002, Annals of epidemiology.

[16]  D. Mark,et al.  Medical economics and the assessment of value in cardiovascular medicine: Part I. , 2002, Circulation.

[17]  P. Lavori,et al.  Cost-Effectiveness of a Conservative, Ischemia-Guided Management Strategy After Non–Q-Wave Myocardial Infarction: Results of a Randomized Trial , 2002, Circulation.

[18]  Jerome Sacks,et al.  Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. , 2002, Journal of the American College of Cardiology.

[19]  The Time Investigators.  Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.

[20]  Mitchell W. Krucoff,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.

[21]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[22]  F. Grover,et al.  A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of , 1999, Controlled clinical trials.

[23]  M. Mcgrath.  Cost Effectiveness in Health and Medicine. , 1998 .

[24]  D. Faxon,et al.  Myocardial revascularization in 1997: angioplasty versus bypass surgery. , 1997, American family physician.

[25]  I. Palacios,et al.  Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). , 1996, Journal of the American College of Cardiology.

[26]  H. Krumholz,et al.  In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. , 1995, Circulation.

[27]  F. Grover,et al.  Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. , 1990, The Annals of thoracic surgery.

[28]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[29]  M. Hlatky.  Economic Comparisons of Coronary Angioplasty and Coronary Bypass Surgery , 2003 .

[30]  D. Mark,et al.  Medical economics and the assessment of value in cardiovascular medicine: Part II. , 2002, Circulation.

[31]  D. Farley,et al.  APCs: reimbursement implications. , 2000, Healthcare financial management : journal of the Healthcare Financial Management Association.

[32]  P. Grimaldi.  Medicare physician fees overhauled. The RBRVS fee system and its implications for hospitals. , 1992, Health progress.